AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
ADARx Pharmaceuticals has priced its upsized IPO at $446.3 million, offering 26,250,000 shares at $17.00 each. The offering is set to close on September 28, 2026.
PUBLIC · ADRXSep 24, 2026
Amount Raised
$446 Million
Round Type
IPO
San DiegoBiotechnologyHealthcareHealth CareTherapeutics
Investors
Life Sci CapitalUbs Investment BankTd CowenMorgan StanleyJ.P. Morgan
Description
ADARx Pharmaceuticals, Inc. announced the pricing of its upsized initial public offering expected to raise approximately $446.3 million. The shares are set to begin trading on The Nasdaq Global Select Market on September 25, 2026. Lead managers for the offering include J.P
Company Information
Company
ADARx Pharmaceuticals, Inc.
Location
5871 OBERLIN DRIVE, SUITE 200
San Diego, California, United States
About
ADARx Pharmaceuticals is a newly launched next-wave genetic medicine company focusing on oligonucleotide therapeutics for inhibition, degradation and base editing of mRNA transcripts. With RNA as the target of our drug discovery, we are capable of working on a wide range of diseases and are currently focusing on genetic, cardiometabolic, and central nervous system (CNS) diseases. We are driven by our mission to turn cutting-edge science into life-saving therapeutics and our desire to provide hope for patients with intractable disease.
We are well-financed with backup from a group of renowned VC funds, and our brand-new laboratory is located in San Diego, California.
Fundz sees it the moment ADARx Pharmaceuticals, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.